BlackRock’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

BlackRock’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-90,036	Closed	-$18K	–	5134
2019 Q3	$18K	Sell	90,036 -21,902	-20%	-$14.8K	﹤0.01%	4661
2019 Q2	$97K	Sell	111,938 -689,960	-86%	-$1.08M	﹤0.01%	4478
2019 Q1	$1.86M	Buy	801,898 +12,871	+2%	+$34.9K	﹤0.01%	3733
2018 Q4	$1.83M	Sell	789,027 -251,230	-24%	-$2.21M	﹤0.01%	3707
2018 Q3	$15.4M	Buy	1,040,257 +29,919	+3%	+$475K	﹤0.01%	3009
2018 Q2	$15.3M	Buy	1,010,338 +97,162	+11%	+$1.65M	﹤0.01%	3013
2018 Q1	$17.1M	Buy	913,176 +408,806	+81%	+$7.15M	﹤0.01%	2852
2017 Q4	$9.15M	Buy	504,370 +280,056	+125%	+$5.92M	﹤0.01%	3189
2017 Q3	$4.99M	Buy	+224,314	New	+$4.92M	﹤0.01%	3466

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BlackRock's SNNA Position: Q4 2019 in Review

BlackRock sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 90,036 shares — an estimated $18K sold.

BlackRock first reported a position in SNNA in Q3 2017 and held it in 9 quarters. The position peaked at $17.1M in Q1 2018. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

BlackRock reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
BlackRock sold 90,036 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $18K.
BlackRock first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 9 quarters.
BlackRock's Sienna Biopharmaceuticals, Inc. position peaked at $17.1M in Q1 2018.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.